메뉴 건너뛰기




Volumn 79, Issue 1, 2013, Pages 154-158

Dabigatran: A primer for neurosurgeons

Author keywords

Anticoagulants; Benzimidazoles; Blood coagulation; Direct thrombin inhibitors; Intracranial hemorrhages; Perioperative period

Indexed keywords

DABIGATRAN; DABIGATRAN ETEXILATE; WARFARIN;

EID: 84873735943     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2012.06.019     Document Type: Review
Times cited : (6)

References (21)
  • 1
    • 45949103309 scopus 로고    scopus 로고
    • Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
    • J. Ansell, J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, G. Palareti Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 160S 198S
    • (2008) Chest , vol.133
    • Ansell, J.1    Hirsh, J.2    Hylek, E.3    Jacobson, A.4    Crowther, M.5    Palareti, G.6
  • 3
    • 67849126841 scopus 로고    scopus 로고
    • Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents
    • M.A. Crowther, T.E. Warkentin Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents J Thromb Haemost 7 Suppl 1 2009 107 110
    • (2009) J Thromb Haemost , vol.7 , Issue.SUPPL. 1 , pp. 107-110
    • Crowther, M.A.1    Warkentin, T.E.2
  • 4
    • 80053571188 scopus 로고    scopus 로고
    • Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects
    • E.S. Eerenberg, P.W. Kamphuisen, M.K. Sijpkens, J.C. Meijers, H.R. Buller, M. Levi Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects Circulation 124 2011 1573 1579
    • (2011) Circulation , vol.124 , pp. 1573-1579
    • Eerenberg, E.S.1    Kamphuisen, P.W.2    Sijpkens, M.K.3    Meijers, J.C.4    Buller, H.R.5    Levi, M.6
  • 7
    • 79953836474 scopus 로고    scopus 로고
    • Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*) A randomised, double-blind, noninferiority trial
    • RE-NOVATE II Study Group
    • B.I. Eriksson, O.E. Dahl, M.H. Huo, A.A. Kurth, S. Hantel, K. Hermansson, J.M. Schnee, R.J. Friedman RE-NOVATE II Study Group Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*) A randomised, double-blind, noninferiority trial Thromb Haemost 105 2011 721 729
    • (2011) Thromb Haemost , vol.105 , pp. 721-729
    • Eriksson, B.I.1    Dahl, O.E.2    Huo, M.H.3    Kurth, A.A.4    Hantel, S.5    Hermansson, K.6    Schnee, J.M.7    Friedman, R.J.8
  • 8
    • 79551638273 scopus 로고    scopus 로고
    • Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism
    • B.I. Eriksson, D.J. Quinlan, J.W. Eikelboom Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism Annu Rev Med 62 2011 41 57
    • (2011) Annu Rev Med , vol.62 , pp. 41-57
    • Eriksson, B.I.1    Quinlan, D.J.2    Eikelboom, J.W.3
  • 9
    • 84855611604 scopus 로고    scopus 로고
    • Dabigatran in atrial fibrillation: Pharmacology and clinical trials
    • M.D. Ezekowitz, R. Nagarakanti Dabigatran in atrial fibrillation: pharmacology and clinical trials J Interv Card Electrophysiol 32 2011 173 180
    • (2011) J Interv Card Electrophysiol , vol.32 , pp. 173-180
    • Ezekowitz, M.D.1    Nagarakanti, R.2
  • 10
    • 46049090201 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
    • W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, M.R. Lassen, C.W. Colwell Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 381S 453S
    • (2008) Chest , vol.133
    • Geerts, W.H.1    Bergqvist, D.2    Pineo, G.F.3    Heit, J.A.4    Samama, C.M.5    Lassen, M.R.6    Colwell, C.W.7
  • 11
    • 79951688186 scopus 로고    scopus 로고
    • Changing anticoagulant paradigms for atrial fibrillation: Dabigatran, apixaban and rivaroxaban
    • M.A. Giorgi, H. Cohen Arazi, C.D. Gonzalez, G. Di Girolamo Changing anticoagulant paradigms for atrial fibrillation: dabigatran, apixaban and rivaroxaban Expert Opin Pharmacother 12 2011 567 577
    • (2011) Expert Opin Pharmacother , vol.12 , pp. 567-577
    • Giorgi, M.A.1    Cohen Arazi, H.2    Gonzalez, C.D.3    Di Girolamo, G.4
  • 13
    • 79954456496 scopus 로고    scopus 로고
    • Dabigatran etexilate: A new oral thrombin inhibitor
    • G.J. Hankey, J.W. Eikelboom Dabigatran etexilate: a new oral thrombin inhibitor Circulation 123 2011 1436 1450
    • (2011) Circulation , vol.123 , pp. 1436-1450
    • Hankey, G.J.1    Eikelboom, J.W.2
  • 14
    • 36549087247 scopus 로고    scopus 로고
    • Status of the epidemiology of atrial fibrillation
    • W.B. Kannel, E.J. Benjamin Status of the epidemiology of atrial fibrillation Med Clin North Am 92 2008 17 40
    • (2008) Med Clin North Am , vol.92 , pp. 17-40
    • Kannel, W.B.1    Benjamin, E.J.2
  • 15
    • 33750023407 scopus 로고    scopus 로고
    • Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: A population model analysis
    • K.H. Liesenfeld, H.G. Schafer, I.F. Troconiz, C. Tillmann, B.I. Eriksson, J. Stangier Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis Br J Clin Pharmacol 62 2006 527 537
    • (2006) Br J Clin Pharmacol , vol.62 , pp. 527-537
    • Liesenfeld, K.H.1    Schafer, H.G.2    Troconiz, I.F.3    Tillmann, C.4    Eriksson, B.I.5    Stangier, J.6
  • 18
    • 45949095568 scopus 로고    scopus 로고
    • Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
    • D.E. Singer, G.W. Albers, J.E. Dalen, M.C. Fang, A.S. Go, J.L. Halperin, G.Y. Lip, W.J. Manning Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 546S 592S
    • (2008) Chest , vol.133
    • Singer, D.E.1    Albers, G.W.2    Dalen, J.E.3    Fang, M.C.4    Go, A.S.5    Halperin, J.L.6    Lip, G.Y.7    Manning, W.J.8
  • 19
    • 77953168824 scopus 로고    scopus 로고
    • Dabigatran etexilate - A novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
    • J. van Ryn, J. Stangier, S. Haertter, K.H. Liesenfeld, W. Wienen, M. Feuring, A. Clemens Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127
    • (2010) Thromb Haemost , vol.103 , pp. 1116-1127
    • Van Ryn, J.1    Stangier, J.2    Haertter, S.3    Liesenfeld, K.H.4    Wienen, W.5    Feuring, M.6    Clemens, A.7
  • 20
    • 84856807170 scopus 로고    scopus 로고
    • Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment
    • M. Watanabe, F.M. Siddiqui, A.I. Qureshi Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment Neurocrit Care 16 2012 203 209
    • (2012) Neurocrit Care , vol.16 , pp. 203-209
    • Watanabe, M.1    Siddiqui, F.M.2    Qureshi, A.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.